|Inogen -- USA Stock|| |
USD 141.08 0.15 0.11%
Co-Founder and VP of Marketing
Mr. Byron Myers is Executive Vice President of Sales and Marketing of Inogen, Inc., He is a cofounder of Inogen and has served as our Executive Vice President, Sales and Marketing since January 1, 2017. Previously, Mr. Myers served as our Vice President, Marketing from 2011 to 2016. In his current role, Mr. Myers leads Inogens Global Sales, Marketing and Product Management Operations. Prior to serving in this position, Mr. Myers held various roles with our company, including Product Manager from 2002 to 2006, Director of Marketing from 2006 to 2007 and 2008 to 2011, International Product Manager during 2007, and Director of International Product Management from 2007 to 2008
Age: 36 Founder Since 2017 MBA
Myers received a Bachelor?s degree in Economics/Mathematics from the University of California, Santa Barbara and an MBA from the Rady School of Management at the University of California, San Diego.
Byron Myers Latest Insider Activity
The company has return on total asset (ROA)
of 7.32 %
which means that it generated profit of $7.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE)
of 10.27 %
meaning that it created $10.27 on every $100 dollars invested by stockholders.
Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California. Inogen operates under Medical Devices classification in USA and traded on NASDAQ. It employs 770 people.Inogen (INGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 770 people. Inogen is listed under Medical Equipment category by Fama And French industry classification.
Inogen Leadership Team
|Scott Beardsley, Director|
|Byron Myers, Founder, MBA|
|Raymond Huggenberger, CEO|
|Heath Lukatch, Chairman, Ph.D|
|Heather Rider, Director, MBA|
|Loren McFarland, Director, CFA|
|Scott Greer, Director, MBA|
|Benjamin AndersonRay, Director, MBA|
|Matthew Scribner, President, MBA|
|Alison Bauerlein, Founder|
|Scott Wilkinson, COO, MBA|
|Brenton Taylor, Founder|
Stock Performance Indicators
Most of Macroaxis users are currently bullish on Inogen. What is your judgment towards investing in Inogen? Are you bullish or bearish?
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations